GlassScriptPhysician profile
Matthew Robert Wilber
NPI 1114904257
$62,706.85
in general payments reported to CMS, 2019-2025
20 companies · $769 in 2025
The $769 reported for 2025 was more than what 83% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $1,098 · 2021: $16K · 2022: $18K · 2023: $744 · 2024: $1,976 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775 · Travel and Lodging: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.21 |
| Travel and Lodging | $713.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $32,813.26 | 2019-2023 | Oasis |
| Osiris Therapeutics INC. | $12,931.29 | 2019 | |
| Inari Medical, INC. | $11,946.44 | 2020-2022 | |
| Stryker Corporation | $2,140.79 | 2021-2025 | Prostep, Ortholoc 3di, Dart-Fire |
| Treace Medical Concepts, INC. | $869.76 | 2022-2025 | |
| Convatec INC. | $663.60 | 2021-2024 | |
| Kerecis Limited | $615.05 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $225.98 | 2019-2022 | |
| Depuy Synthes Sales INC. | $165.28 | 2022 | |
| Medshape, INC. | $65.52 | 2024 | Lapidus Correction Jig, Right, Dynanail Helix, Washer, 15 Mm |
| Zimmer Biomet Holdings, INC. | $51.36 | 2019 | |
| Stimlabs LLC | $47.98 | 2025 | Corplex P |
| Kci USA, INC. | $34.32 | 2019 | |
| Biogennix, LLC | $31.75 | 2022 | |
| Misonix INC | $25.51 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $20.79 | 2024 | Physio-Stim |
| Bayer Healthcare Pharmaceuticals INC. | $17.73 | 2025 | |
| Paratek Pharmaceuticals, INC. | $14.61 | 2025 | Nuzyra |
| Coloplast Corp | $13.97 | 2022 | |
| Horizon Therapeutics Plc | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Wilber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.